11.73
price up icon0.26%   0.03
 
loading
Precedente Chiudi:
$11.70
Aprire:
$11.83
Volume 24 ore:
17.89M
Relative Volume:
4.88
Capitalizzazione di mercato:
$1.31B
Reddito:
$631.73M
Utile/perdita netta:
$-239.78M
Rapporto P/E:
-5.8069
EPS:
-2.02
Flusso di cassa netto:
$-33.45M
1 W Prestazione:
+8.51%
1M Prestazione:
+36.55%
6M Prestazione:
-19.60%
1 anno Prestazione:
-40.91%
Intervallo 1D:
Value
$11.35
$11.83
Intervallo di 1 settimana:
Value
$10.47
$12.11
Portata 52W:
Value
$6.78
$24.76

10 X Genomics Inc Stock (TXG) Company Profile

Name
Nome
10 X Genomics Inc
Name
Telefono
(925) 401-7300
Name
Indirizzo
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
Dipendente
1,306
Name
Cinguettio
@10xgenomics
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
TXG's Discussions on Twitter

Confronta TXG con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Health Information Services icon
TXG
10 X Genomics Inc
11.73 1.31B 631.73M -239.78M -33.45M -2.02
Health Information Services icon
VEEV
Veeva Systems Inc
283.41 46.43B 2.86B 780.66M 1.20B 4.72
Health Information Services icon
TEM
Tempus Ai Inc
66.52 12.01B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
DOCS
Doximity Inc
61.09 10.79B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
HQY
Healthequity Inc
104.88 9.27B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
WAY
Waystar Holding Corp
39.76 7.03B 906.14M -52.62M 89.62M -0.3621

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-13 Downgrade Leerink Partners Outperform → Market Perform
2024-09-03 Iniziato Leerink Partners Outperform
2024-07-22 Aggiornamento Jefferies Hold → Buy
2024-07-18 Downgrade JP Morgan Overweight → Neutral
2024-07-10 Downgrade Deutsche Bank Buy → Hold
2024-06-27 Downgrade Wolfe Research Outperform → Peer Perform
2024-06-25 Downgrade Guggenheim Buy → Neutral
2024-06-03 Ripresa Jefferies Hold
2024-05-01 Downgrade TD Cowen Buy → Hold
2023-12-14 Iniziato Guggenheim Buy
2023-12-13 Iniziato Wolfe Research Outperform
2023-12-12 Aggiornamento BofA Securities Underperform → Neutral
2023-07-05 Ripresa JP Morgan Overweight
2023-05-10 Iniziato Barclays Overweight
2023-03-31 Iniziato Stephens Overweight
2023-02-02 Iniziato UBS Neutral
2022-12-14 Iniziato Deutsche Bank Buy
2022-08-18 Downgrade Goldman Neutral → Sell
2022-07-25 Iniziato Canaccord Genuity Buy
2022-07-15 Downgrade BofA Securities Neutral → Underperform
2022-07-15 Downgrade William Blair Outperform → Mkt Perform
2021-10-15 Ripresa Cowen Outperform
2021-09-14 Downgrade BofA Securities Buy → Neutral
2021-03-15 Iniziato William Blair Outperform
2020-12-02 Iniziato Goldman Neutral
2020-09-09 Iniziato Morgan Stanley Overweight
2020-07-10 Iniziato Stifel Buy
2020-03-05 Iniziato Guggenheim Buy
2020-01-07 Iniziato Citigroup Buy
2019-10-07 Iniziato BofA/Merrill Buy
2019-10-07 Iniziato Cowen Outperform
2019-10-07 Iniziato JP Morgan Overweight
2019-09-24 Iniziato Evercore ISI Outperform
Mostra tutto

10 X Genomics Inc Borsa (TXG) Ultime notizie

pulisher
Jun 18, 2025

10x Genomics Inc (TXG) Trading 4.12% Higher on Jun 18 - GuruFocus

Jun 18, 2025
pulisher
Jun 17, 2025

UPC Backs Sales Ban On Kits Infringing 10x Genomics Patent - Law360

Jun 17, 2025
pulisher
Jun 16, 2025

Delta, Macy's, CECO Environmental, RadNet, and 10x Genomics Shares Skyrocket, What You Need To Know - Yahoo Finance

Jun 16, 2025
pulisher
Jun 16, 2025

Layoff Tracker: Gilead Cuts 36 Employees in California - BioSpace

Jun 16, 2025
pulisher
Jun 12, 2025

Molecular Diagnostics for Cancer Market Research 2025: Advances in Personalized Medicine and Liquid Biopsies Reshape Industry Landscape - GlobeNewswire Inc.

Jun 12, 2025
pulisher
Jun 10, 2025

Brown Capital Management Small Company Fund Sold 10x Genomics (TXG) Due to Fundamental Concerns - Insider Monkey

Jun 10, 2025
pulisher
Jun 10, 2025

10x Genomics, Inc. (TXG) Stock Analysis: Evaluating a 28% Potential Upside for Investors - DirectorsTalk Interviews

Jun 10, 2025
pulisher
Jun 04, 2025

Forecasting The Future: 7 Analyst Projections For 10x Genomics - Benzinga

Jun 04, 2025
pulisher
Jun 04, 2025

Long Read Sequencing Market Key Players Analysis10X Genomics, - openPR.com

Jun 04, 2025
pulisher
Jun 04, 2025

10x Genomics, Inc. (NASDAQ:TXG) Stock Holdings Increased by Deutsche Bank AG - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

ARK Investment Acquires 290K Shares of 10x Genomics (TXG) | TXG Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

10x Genomics, Inc. (TXG) Stock Analysis: Evaluating the 31.90% Potential Upside - DirectorsTalk Interviews

Jun 03, 2025
pulisher
Jun 02, 2025

Cathie Wood's ARK Investment Acquires Significant Stake in 10x G - GuruFocus

Jun 02, 2025
pulisher
Jun 01, 2025

10 Promising Biotech Stocks to Invest in (June 2025) - Securities.io

Jun 01, 2025
pulisher
May 31, 2025

ARK Investment Acquires 342K Shares of 10x Genomics (TXG) | TXG Stock News - GuruFocus

May 31, 2025
pulisher
May 31, 2025

Cetera Investment Advisers Raises Stake in 10x Genomics, Inc. (NASDAQ:TXG) - Defense World

May 31, 2025
pulisher
May 31, 2025

Cathie Wood’s ARK buys Intellia, 10x Genomics, sells Tesla stock By Investing.com - Investing.com India

May 31, 2025
pulisher
May 30, 2025

Cathie Wood’s ARK buys Intellia, 10x Genomics, sells Tesla stock - Investing.com

May 30, 2025
pulisher
May 30, 2025

10x Genomics, Inc. (NASDAQ:TXG) Given Average Recommendation of “Hold” by Analysts - Defense World

May 30, 2025
pulisher
May 27, 2025

Powell, Mayville Engineering, Graham Corporation, Hyster-Yale Materials Handling, and 10x Genomics Shares Skyrocket, What You Need To Know - Yahoo Finance

May 27, 2025
pulisher
May 27, 2025

Shareholders May Be Wary Of Increasing 10x Genomics, Inc.'s (NASDAQ:TXG) CEO Compensation Package - simplywall.st

May 27, 2025
pulisher
May 27, 2025

10x Genomics, Inc. (TXG) Stock Analysis: A 52.56% Potential Upside Amidst a Challenging Market - DirectorsTalk Interviews

May 27, 2025
pulisher
May 27, 2025

10x Genomics’ (TXG) “Sell (E+)” Rating Reiterated at Weiss Ratings - Defense World

May 27, 2025
pulisher
May 25, 2025

10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Bank of America Corp DE - Defense World

May 25, 2025
pulisher
May 23, 2025

Why 10x Genomics Stock Was Sliding This Week - Barchart.com

May 23, 2025
pulisher
May 23, 2025

10x Genomics Reports Third Quarter 2023 Financial Results - Seeking Alpha

May 23, 2025
pulisher
May 22, 2025

10x Genomics Reports First Quarter 2024 Financial Results - Seeking Alpha

May 22, 2025
pulisher
May 21, 2025

Gotham Asset Management LLC Takes $264,000 Position in 10x Genomics, Inc. (NASDAQ:TXG) - Defense World

May 21, 2025
pulisher
May 21, 2025

10x Genomics (TXG) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

May 21, 2025
pulisher
May 20, 2025

10x Genomics (NASDAQ:TXG) Price Target Lowered to $18.00 at Morgan Stanley - Defense World

May 20, 2025
pulisher
May 20, 2025

10x Genomics (NASDAQ:TXG) Shares Down 4.8% Following Analyst Downgrade - Defense World

May 20, 2025
pulisher
May 19, 2025

High-Throughput Transcriptomics 2025–2028: Next-Gen Breakthroughs Set to Disrupt Genomics Market - macnifico.pt

May 19, 2025
pulisher
May 19, 2025

10x Genomics (TXG) Price Target Lowered by Morgan Stanley | TXG Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

10x Genomics, Inc. (NASDAQ:TXG) Shares Sold by Northern Trust Corp - Defense World

May 19, 2025
pulisher
May 17, 2025

Stephens Reaffirms Overweight Rating for 10x Genomics (NASDAQ:TXG) - Defense World

May 17, 2025
pulisher
May 16, 2025

'Shooting ourselves in the foot': Trump administration cuts force East Bay’s 10x Genomics into layoffs - The Business Journals

May 16, 2025
pulisher
May 16, 2025

Dimensional Fund Advisors LP Sells 23,956 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - Defense World

May 16, 2025
pulisher
May 15, 2025

NanoString to pay 10x Genomics $68m in global settlement - Life Sciences Intellectual Property Review

May 15, 2025
pulisher
May 15, 2025

10x Genomics reaches settlement with Bruker - Medical Buyer

May 15, 2025
pulisher
May 15, 2025

Stifel Financial Corp Raises Holdings in 10x Genomics, Inc. (NASDAQ:TXG) - Defense World

May 15, 2025
pulisher
May 15, 2025

UBS Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $12.00 - Defense World

May 15, 2025
pulisher
May 14, 2025

10x Genomics Reaches $68 Million Patent Settlement With Bruker - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

10x Genomics Settles Litigation with Bruker Corporation - TipRanks

May 14, 2025
pulisher
May 14, 2025

10x Genomics settles patent dispute with Bruker for $68 million - Investing.com

May 14, 2025
pulisher
May 14, 2025

10x Genomics Announces Patent Litigation Settlement Agreement with Bruker - Financial Times

May 14, 2025

10 X Genomics Inc Azioni (TXG) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

10 X Genomics Inc Azioni (TXG) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Hindson Benjamin J.
See Remarks
May 22 '25
Sale
8.30
7,485
62,120
448,374
Taich Adam
Chief Financial Officer
May 22 '25
Sale
8.30
4,044
33,562
331,588
$20.61
price up icon 0.59%
$11.38
price down icon 0.35%
$22.00
price up icon 0.00%
$46.51
price up icon 3.45%
$23.54
price up icon 1.99%
health_information_services WAY
$39.76
price up icon 1.25%
Capitalizzazione:     |  Volume (24 ore):